Tierarztl Prax Ausg K Kleintiere Heimtiere 2005; 33(03): 197-201
DOI: 10.1055/s-0037-1622464
Hund/Katze
Schattauer GmbH

Prävalenz von Antikörpern gegen Bordetella bronchiseptica in Mehrkatzenhaushalten

Prevalence of antibodies against Bordetella bronchiseptica in multi-cat households
Judit Zapirain Gastón
1   Aus der Medizinischen Kleintierklinik (Vorstand: Prof. Dr. K. Hartmann) der Ludwig-Maximilians-Universität München
,
Christiane Stengel
1   Aus der Medizinischen Kleintierklinik (Vorstand: Prof. Dr. K. Hartmann) der Ludwig-Maximilians-Universität München
,
D. Harbour
2   Department of Clinical Veterinary Science Division, University of Bristol, Bristol, United Kingdom
,
St. Krieger
3   Institut für Statistik (Vorstand: Prof. Dr. G. Tutz) der Ludwig-Maximilians-Universität München
,
Susanne Stampf
3   Institut für Statistik (Vorstand: Prof. Dr. G. Tutz) der Ludwig-Maximilians-Universität München
,
Katrin Hartmann
1   Aus der Medizinischen Kleintierklinik (Vorstand: Prof. Dr. K. Hartmann) der Ludwig-Maximilians-Universität München
› Author Affiliations
Further Information

Publication History

Eingegangen: 03 June 2004

akzeptiert: 28 January 2004

Publication Date:
05 January 2018 (online)

Zusammenfassung

Gegenstand und Ziel: Mit dieser Studie sollte das Vorkommen von Bordetella (B.) bronchiseptica in Mehrkatzenhaushalten mit und ohne respiratorische Symptome untersucht werden. Material und Methoden: Die Studie umfasste insgesamt 258 Katzen aus 40 Beständen. Antikörper gegen B. bronchiseptica wurden mittels ELISA nachgewiesen. Zudem erfolgten eine PCR und eine Erregeranzüchtung. Ergebnisse: Die Antikörperprävalenz lag bei 41,9%. Bei Katzen mit respiratorischen Symptomen ergab sich eine Prävalenz von 56,5%, bei gesunden Katzen betrug sie 39,9%. Dieser Unterschied war statistisch signifikant. Die Antikörperprävalenz lag in Tierheimen signifikant höher als in Privat- und Zuchtbeständen. Ältere Katzen wiesen signifikant häufiger Antikörper gegen B. bronchiseptica auf. Die PCR war nur bei 4,6% von 219 untersuchten Katzen positiv; die Anzüchtung gelang bei keinem von 28 untersuchten Tieren. Schlussfolgerung und klinische Relevanz: B. bronchiseptica zeigt in Mehrkatzenhaushalten eine weite Verbreitung. Vor allem in Tierheimen sind Katzen offenbar einem hohen Infektionsrisiko ausgesetzt. Eine Impfung ist daher besonders in Tierheimen in Betracht zu ziehen.

Summary

Objective: The aim of this study was to determine the prevalence of Bordetella (B.) bronchiseptica in multi-cat households with and without respiratory tract disease. Material and methods: In total, 258 cats of 40 households were examined. B. bronchiseptica antibodies were determined by ELISA. In addition, PCR and bacterial culture were performed. Results: Overall, antibody prevalence was 41.9%. In cats with respiratory problems, antibody prevalence was 56.5%, in healthy cats 39.9%. This difference was statistically significant. Shelters displayed a significantly higher antibody prevalence than private households or breeding catteries. Cats of older age had an increased risk of being B. bronchiseptica antibody-positive. Only 4.6% of 219 examined cats showed a positive PCR-result. Bacterial culture was negative in all 28 examined cats. Conclusions and clinical relevance: B. bronchiseptica appears to be wide-spread in multi-cat households. Especially in animal shelters, risk of infection seems to be high, and vaccination should be considered in such an environment.

 
  • Literatur

  • 1 Bemis DA, Carmichael LE, Appel MJ. Naturally occurring respiratory disease in a kennel caused by Bordetella bronchiseptica . Cornell Vet 1977; 67: 282-93.
  • 2 Bemis DA. Bordetella . In: Pathogenesis of Bacterial Infection in Animals. Gyles CL, Thoen CO. eds. Iowa: Iowa State University Press; 1986: 137-46.
  • 3 Bergman JGHE, Vernooij J, Zegers EM. Prevalence of antibodies against Bordetella bronchiseptica in cats with a history of respiratory disease. Vet Quart 1997; 19: 50-1.
  • 4 Binns SH, Speakman AJ, Dawson S, Bennet M. et al. The use of pulsedfield gel electrophoresis to examine the epidemiology of Bordetella bronchiseptica isolated from cats and other species. Epidemiol Infect 1998; 120: 201-8.
  • 5 Binns SH, Dawson S, Speakman AJ, Cuevas LE. et al. Prevalence and risk factors for feline Bordetella bronchiseptica infection. Vet Rec 1999; 144: 575-80.
  • 6 Coutts AJ, Dawson S, Binns S, Hart CA. et al. Studies on natural transmission of Bordetella bronchiseptica in cats. Vet Microbiol 1996; 48: 19-27.
  • 7 Dawson S, Jones D, McCracken CM, Gaskell RM. et al. Bordetella bronchiseptica infection in cats following contact with infected dogs. Vet Rec 2000; 146: 46-8.
  • 8 DiGiacomo RF, Deeb BJ, Giddens WE, Bernard BL. et al. Atrophic rhinitis in New Zealand with rabbits infected with Pasteurella multocida . Am J Vet Res 1989; 50: 1460-5.
  • 9 Fahrmeir L, Tutz G. Multivariate statistical modelling based on generalized linear models. New York: Springer Series in Statistics; 2001: 112-37.
  • 10 Fisk SK, Soave OA. Bordetella bronchiseptica in laboratory cats from central California. Lab Anim Sci 1973; 23: 33-5.
  • 11 Gaskell RM, Dawson S. Viral-induced upper respiratory tract disease. In: Feline Medicine and Therapeutics. Chandler EA, Gaskell CJ. eds. Oxford: Blackwell Science; 1994: 453-72.
  • 12 Gaskell RM, Dawson S, Jacobs AAC, Seawell BW. The role of Bordetella in feline respiratory disease. In: Consultations in Feline Internal Medicine. August JR. Philadelphia: Saunders; 1997: 34-6.
  • 13 Gaskell RM, Dawson S. Feline respiratory disease. In: Infectious Disease of the Dog and Cat. 2nd ed.. Greene CE. ed. Philadelphia: Saunders; 1998: 97-106.
  • 14 Helps CR, Lait P, Damhuis A, Björnehammar U. et al. Factors associated with upper respiratory tract disease in experience from 218 European catteries. Vet Rec. (accepted for publication).
  • 15 Hoskins JD, Williams J, Roy AF, Peters JC. et al. Isolation and characterization of Bordetella bronchiseptica from cats in Southern Louisiana. Vet Immunol Immunopathol 1998; 65: 173-6.
  • 16 Jacobs AA, Chalmers WS, Pasman J, van Vugt S. et al. Feline bordetellosis: challenge and vaccine studies. Vet Rec 1993; 133: 260-3.
  • 17 Jensen JS, Iversen L, Lee MH, Manniche NE. Seroprevalence of antibodies to Bordetella bronchiseptica in the Copenhagen area of Denmark. Vet Rec 1998; 143: 592.
  • 18 Magyar T, Chanter N, Lax AJ, Rutter JM. et al. The pathogenesis of turbinate atrophy in pigs caused by Bordetella bronchiseptica . Vet Microbiol 1988; 18: 135-46.
  • 19 McArdle HC, Dawson S, Coutts AJ, Bennett M. et al. Seroprevalence and isolation rate of Bordetella bronchiseptica in cats in the UK. Vet Rec 1994; 135: 506-7.
  • 20 McGowan JP. Some observations on a laboratory epidemic, principally among dogs and cats, in which the animals affected presented the symptoms of the disease called «distemper”. J Pathol Bacteriol 1911; 15: 372-426.
  • 21 Molyneux JM, Guilford WG, Hunter JEB, Gwozdz M. et al. Prevalence of Bordetella bronchiseptica in cats in New Zealand. New Zealand Vet J 2000; 48: 82-4.
  • 22 Pasmans F, Acke M, Vanrobaeys M, Haesebrouck F. Prevalence of Bordetella bronchiseptica infections in cats from different environments. Vlaams Diergeneeskundig Tijdschrift 2001; 70: 124-6.
  • 23 Pedersen NC. Bordetellosis. In: Feline Infectious Disease. Pedersen NC. Goleta, California: American Veterinary Publications; 1988: 153-4.
  • 24 Pedersen NC. Common infectious diseases of multiple-cat environments. In: Feline Husbandry – Diseases and Management in the Multiple Cat Environment. Pratt PW. ed. Goleta, California: American Veterinary Publications; 1991: 163-288.
  • 25 Pennise MG, Ferat MT, Masucci M, De Majo M. et al. Isolation of Bordetella bronchiseptica in cats: clinical and epidemiological evaluation. Proceedings of the I. A. I. E. V. National Meeting, Palermo, Italy 1999; 18-20.
  • 26 Sawata A, Kume K. Nasal turbinate atrophy in young mice inoculated with Bordetella bronchiseptica of pig origin. Am J Vet Res 1982; 43: 1845-7.
  • 27 Snyder SB, Fisk SK, Fox JG, Soave OA. Respiratory tract disease associated with Bordetella bronchiseptica infection in cats. J Am Vet Med Assoc 1973; 163: 293-4.
  • 28 Speakman AJ. Studies on Bordetella bronchiseptica in cats. PhD thesis 1997, University of Liverpool, Great Britain..
  • 29 Speakman AJ, Dawson S, Binns SH, Gaskell CJ. et al. Bordetella bronchiseptica infection in the cat. J Small Anim Pract 1999; 40: 252-6.
  • 30 Switzer WP, Maré CJ. Hubbard Incidence of Bordetella bronchiseptica in wildlife and man in Iowa. Am J Vet Res 1966; 27: 1134-6.
  • 31 Turnquist SE, Ostlund E. Calicivirus outbreak with high mortality in a Missouri feline colony. J Vet Diagn Invest 1997; 09: 195-8.
  • 32 Tutz G. Die Analyse kategorialer Daten. München: Oldenbourg 2000; 29-114.
  • 33 Welsh RD. Bordetella bronchiseptica infections in cats. J Am Anim Hosp Assoc 1996; 32: 153-8.
  • 34 Willoughby K, Dawson S, Jones RC, Symons M. et al. Isolation of B bronchiseptica from kittens with pneumonia in a breeding cattery. Vet Rec 1991; 129: 407-8.